Definitive Healthcare Corp

Análisis de la acción Definitive Healthcare Corp (DH)

$0.802

-0.012 (-1.47%)Al cierre

Loading chart…
High
0.840
Open
0.820
VWAP
0.80
Vol
190.88K
Mkt Cap
625.05M
Low
0.764
Amount
153.12K
EV/EBITDA, TTM
2.30

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

AI analysis of Definitive Healthcare Corp (DH)

hold

Definitive Healthcare Corp is currently priced at $0.8024, showing a recent 5-day change of +12.37%, which indicates a potential short-term recovery. However, the stock has a concerning RSI of 76.96, suggesting it may be overbought in the short term. Analysts have downgraded their price targets significantly, with Deutsche Bank lowering its target to $1 from $3, indicating a lack of confidence in substantial near-term growth. The main risk is the company's substantial net losses, with a Q1 net income of -$138.6 million, which raises concerns about its long-term viability. Therefore, while there may be short-term gains, the overall outlook suggests holding rather than buying at this time.

Métricas de valoración

The current forward P/E ratio for Definitive Healthcare Corp (DH) is 4.14, compared to its 5-year average forward P/E of 44.58.

Forward P/E

Fair
5Y Average P/E
44.58
Current P/E
4.14
Sobrevalorada
92.41
Infravalorada
-3.25

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
19.80
Current EV/EBITDA
2.30
Sobrevalorada
37.13
Infravalorada
2.48

Forward P/S

Fair
5Y Average P/S
4.56
Current P/S
0.39
Sobrevalorada
8.84
Infravalorada
0.27

Alphio AI Price Scenarios for DH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%DH

$3.73

Precio del escenario

B

Base

Base · 50%DH

$3.39

Precio del escenario

B

Bear

Bear · 25%DH

$3.31

Precio del escenario

Whales holding DH

A

Advent International, L.P.

+ HoldingDH

+36.27%

3M Return

Cronología de eventos

2026-08-10 (ET)

17:00:00

Consensus 18c Narrows FY26 Revenue Outlook to $220M

16:30:00

Definitive Healthcare Q2 Revenue at $55.2M

16:30:00

Sees Q3 Revenue of $54M-$55M

2026-05-07 (ET)

17:20:00

Company Confirms FY26 Revenue Outlook of $220M to $226M

17:20:00

Sees Q2 Revenue of $55M-$56M

Noticias

DH FAQ — answered by Alphio AI

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo). It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Definitive Healthcare Corp is currently priced at $0.8024, showing a recent 5-day change of +12.37%, which indicates a potential short-term recovery. However, the stock has a concerning RSI of 76.96, suggesting it may be overbought in the short term. Analysts have downgraded their price targets significantly, with Deutsche Bank lowering its target to $1 from $3, indicating a lack of confidence in substantial near-term growth. The main risk is the company's substantial net losses, with a Q1 net income of -$138.6 million, which raises concerns about its long-term viability. Therefore, while there may be short-term gains, the overall outlook suggests holding rather than buying at this time.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis